Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Clear Labs Launches Microbial Surveillance Whole Genome Sequencing Solution
  • USA - English


News provided by

Clear Labs

May 22, 2023, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Leader in Next-Generation Sequencing Automation Workflow Solutions Revolutionizes Pathogen Characterization with First Turnkey Solution for Microbial Isolates

SAN CARLOS, Calif., May 22, 2023 /PRNewswire-PRWeb/ -- Clear Labs, a leader in next-generation sequencing automation workflow solutions, announces the launch of the Clear Dx™ Microbial Surveillance WGS, a fully-automated, end-to-end whole genome sequencing (WGS) solution for bacterial and fungal isolates. This groundbreaking application sets a new standard for speed, efficiency and simplicity in pathogen characterization.

Clinicians and public health professionals rely on genomic data to identify and manage outbreaks and antimicrobial resistance, but the existing methods are labor-intensive and time-consuming, hampering effective action. With Clear Dx™ Microbial Surveillance WGS, Clear Labs helps labs address this challenge by providing a turnkey solution that automates the entire WGS process for up to 12 microbial isolates in just 27 hours. This represents a substantial time reduction compared to traditional manual workflows, and the new Clear Labs product requires only minutes of hands-on time.

"Clear Labs is dedicated to empowering our customers with the tools they need to identify and combat pathogens in their communities and institutions," stated Sasan Amini, Ph.D, Co-Founder and CEO of Clear Labs. "Microbial Surveillance WGS enables near real-time outbreak identification, as opposed to days or weeks later. This could translate into faster intervention, fewer illnesses, better patient outcomes, and reduced economic burden."

Laboratories contribute to federally funded sequencing initiatives that require strict submission and acceptance criteria. Clear Labs' technology aligns seamlessly with these initiatives, conforming to existing standards and facilitating a smooth transition from a manual workflow to a fully automated workflow. Amini commented, "Proper funding and advanced technology can help clinicians and public health authorities effectively combat emerging infections. Microbial infections affect millions of people annually and cost the country billions of dollars each year. By filling a critical gap in the equation, we believe our solution can make a substantial impact."

The Nebraska Public Health Laboratory (NPHL) has been a long-term collaborator of Clear Labs on the Clear Dx™ System and was excited to help validate the new Microbial Surveillance WGS solution. "Staff at the Nebraska laboratory welcomed the opportunity to work with Clear Labs early in the pandemic and was very interested in expanding the collaboration to include a fully automated workflow for bacterial WGS," expressed Dr. Pete Iwen, Director of the NPHL. "The rapid time to result and ease of use enables our lab to get more sequencing done much faster, which provides our stakeholders with actionable information that positively impacts public health."

Clear Labs' Microbial Surveillance WGS represents a significant advancement in the field of pathogen characterization, offering unparalleled speed, automation, and accuracy. With this groundbreaking solution, Clear Labs continues to redefine the landscape of whole genome sequencing and empower laboratories to safeguard health more efficiently than ever before.

The Clear Dx™ Microbial Surveillance WGS solution provides:

  • Sample-to-answer, End-to-end Automation: Eliminate manual handling and time-consuming processes. With Clear Dx™, labs benefit from fully-automated library preparation and management, including cDNA synthesis, target amplification, indexing, and nucleic acid clean-up. This automation ensures greater accuracy and consistency in sample processing.
  • Simplified WGS Workflow: Clear Dx™ simplifies the entire whole genome sequencing workflow, minimizing hands-on time to    about 30 minutes. Unlike existing manual WGS workflows that require several dozen touch points, Clear Dx™ requires one touch point and significantly reduces the complexity and manual intervention, enabling operators to perform whole genome sequencing with minimal training required.
  • Faster Results: Time is of the essence, and Clear Dx™ delivers. With Clear Dx™ technology, labs can expect faster results, with a turnaround time of just a single day compared to the several days (sometimes weeks) required by traditional methods. Rapid sequencing enables you to obtain critical genomic data quickly, empowering timely decision-making.
  • Improved Consistency and Accuracy: Clear Dx™ automation eliminates human variability and ensures uniformity throughout the sequencing process, leading to reliable and reproducible results.
  • Decreased Labor Costs and Increased Lab Productivity: Clear Dx™ optimizes a lab's efficiency by reducing manual labor and reducing time required for repetitive tasks.

Whole genome sequencing of pathogenic isolates has many applications in a broad range of settings, including hospital labs, public health labs, and commercial laboratories: "A rapid, fully automated whole genome sequencing platform can help epidemiologists, infection control specialists, microbiologists to more quickly identify antimicrobial resistant organisms and understand if they have an outbreak on their hands," said Amini. "We believe hospitals can save money, avoid penalties, and improve patient outcomes with this technology."

Additionally, Clear Labs aims to aid the battle against antimicrobial resistance, another major initiative within the clinical and public health communities. "The identification of antimicrobial resistance signatures is critical to understanding how these organisms are evolving, exchanging genetic information, and informs our use and development of antibiotics, which are becoming increasingly less effective," said Amini. "Our platform can deliver those insights much more quickly and more importantly in an actionable timeframe."

For more information about Clear Dx and Microbial Surveillance WGS, please contact [email protected].

About Clear Labs
Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating the only fully-automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity. Clear Labs' turnkey platform accelerates outcomes and improves accuracy. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow's novel pathogens. For more information, visit https://www.clearlabs.com/.

Media Contact

Aimee Eichelberger, Superior PR, (3120 952-1528, [email protected]

SOURCE Clear Labs

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.